- Home
- OPY vs MAZE Comparison
OPY vs MAZE Comparison
Compare OPY & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPY
- MAZE
- Stock Information
- Founded
- OPY 1881
- MAZE 2018
- Country
- OPY United States
- MAZE United States
- Employees
- OPY N/A
- MAZE N/A
- Industry
- OPY Investment Bankers/Brokers/Service
- MAZE
- Sector
- OPY Finance
- MAZE
- Exchange
- OPY Nasdaq
- MAZE NYSE
- Market Cap
- OPY 638.4M
- MAZE 523.1M
- IPO Year
- OPY N/A
- MAZE 2025
- Fundamental
- Price
- OPY $52.65
- MAZE $9.12
- Analyst Decision
- OPY
- MAZE Strong Buy
- Analyst Count
- OPY 0
- MAZE 3
- Target Price
- OPY N/A
- MAZE $25.67
- AVG Volume (30 Days)
- OPY 25.7K
- MAZE 316.7K
- Earning Date
- OPY 04-25-2025
- MAZE 01-01-0001
- Dividend Yield
- OPY 1.27%
- MAZE N/A
- EPS Growth
- OPY 145.95
- MAZE N/A
- EPS
- OPY 6.37
- MAZE 1.25
- Revenue
- OPY $1,344,515,000.00
- MAZE $167,500,000.00
- Revenue This Year
- OPY N/A
- MAZE N/A
- Revenue Next Year
- OPY N/A
- MAZE N/A
- P/E Ratio
- OPY $9.47
- MAZE $7.46
- Revenue Growth
- OPY 13.93
- MAZE N/A
- 52 Week Low
- OPY $36.93
- MAZE $9.30
- 52 Week High
- OPY $73.12
- MAZE $17.00
- Technical
- Relative Strength Index (RSI)
- OPY 22.20
- MAZE N/A
- Support Level
- OPY $58.16
- MAZE N/A
- Resistance Level
- OPY $60.46
- MAZE N/A
- Average True Range (ATR)
- OPY 1.37
- MAZE 0.00
- MACD
- OPY -0.58
- MAZE 0.00
- Stochastic Oscillator
- OPY 0.00
- MAZE 0.00
About OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.